1: Home (ALT-H)
2: HMA Joint (ALT-M)
3: Human Medicines (ALT-U)
- 3.1: Heads of Agencies (ALT-E)
- 3.2: CMDh (ALT-C)
- 3.3: MRI Product Index (ALT-R)
- 3.4: Directory (ALT-I)
4: Veterinary Medicines (ALT-V)

You are here: Human Medicines > CMDh > About CMDh > CMDh Activities

3.2.1: About CMDh (ALT-O)
- 3.2.1.1: CMDh Composition (ALT-P)
- 3.2.1.2: CMDh Activities (ALT-T)
- 3.2.1.3: CMDh Workplan (ALT-W)
- 3.2.1.4: CMDh Reports (ALT-S)
- 3.2.1.5: Contacts with Representative Organisations (ALT-N)
- 3.2.1.6: Transparency Measures (ALT-Y)
- 3.2.1.7: Calendar for CMDh meetings (ALT-L)
- 3.2.1.8: MRFG (1995-2005) (ALT-G)
3.2.2: Statistics
3.2.3: Press Releases
3.2.4: Procedural Guidance
3.2.5: CMDh-Referrals
3.2.6: Product Information
3.2.7: Advice from CMDh
3.2.8: Templates
3.2.9: CMD subgroups / working groups (ALT-K)
3.2.10: Paediatric Regulation
3.2.11: Questions & Answers (ALT-Q)
3.2.12: Contact Form
3.2.13: Contact Points
3.2.14: What's new history

CMDh Activities

CMDh Rules of Procedure (July 2011)

Functions and tasks for CMDh

Role of the Vice Chairperson of the CMDh

Q & A on 'Requests for Advice from CMDh

Evaluation of the functioning of the CMDh

Further to the questionnaires to CMDh Members and Interested Parties which purpose was to evaluate the functioning of the CMDh and consider how further improvements in the operation of the Group can be achived, the CMDh has published a report with a summary of the responses to the various sections of the questionnaires, and the main actions proposed to address the issues raised.